Global Entyvio (vedolizumab) Drug Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Publisher Name :
Date: 12-Sep-2018
No. of pages: 107

Vedolizumab is a monoclonal antibody medicine developed by Takeda Pharmaceuticals for the treatment of ulcerative colitis and Crohn's disease.

Scope of the Report:

This report focuses on the Entyvio (vedolizumab) Drug in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The worldwide market for Entyvio (vedolizumab) Drug is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

- Takeda

Market Segment by Regions, regional analysis covers

- North America (United States, Canada and Mexico)

- Europe (Germany, France, UK, Russia and Italy)

- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

- South America (Brazil, Argentina, Colombia etc.)

- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- Type 1

- Type 2

Market Segment by Applications, can be divided into

- Ulcerative Colitis

- Crohn's Disease

There are 15 Chapters to deeply display the global Entyvio (vedolizumab) Drug market.

Chapter 1, to describe Entyvio (vedolizumab) Drug Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Entyvio (vedolizumab) Drug, with sales, revenue, and price of Entyvio (vedolizumab) Drug, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Entyvio (vedolizumab) Drug, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Entyvio (vedolizumab) Drug market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Entyvio (vedolizumab) Drug sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Global Entyvio (vedolizumab) Drug Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Table of Contents
1 Market Overview
1.1 Entyvio (vedolizumab) Drug Introduction
1.2 Market Analysis by Type
1.2.1 Type 1
1.2.2 Type 2
1.3 Market Analysis by Applications
1.3.1 Ulcerative Colitis
1.3.2 Crohn's Disease
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Takeda
2.1.1 Business Overview
2.1.2 Entyvio (vedolizumab) Drug Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Takeda Entyvio (vedolizumab) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Entyvio (vedolizumab) Drug Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Entyvio (vedolizumab) Drug Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Entyvio (vedolizumab) Drug Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Entyvio (vedolizumab) Drug Manufacturer Market Share in 2017
3.3.2 Top 6 Entyvio (vedolizumab) Drug Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Entyvio (vedolizumab) Drug Market Analysis by Regions
4.1 Global Entyvio (vedolizumab) Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Entyvio (vedolizumab) Drug Sales and Market Share by Regions (2013-2018)
4.1.2 Global Entyvio (vedolizumab) Drug Revenue and Market Share by Regions (2013-2018)
4.2 North America Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
4.3 Europe Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
4.5 South America Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
5 North America Entyvio (vedolizumab) Drug by Countries
5.1 North America Entyvio (vedolizumab) Drug Sales, Revenue and Market Share by Countries
5.1.1 North America Entyvio (vedolizumab) Drug Sales and Market Share by Countries (2013-2018)
5.1.2 North America Entyvio (vedolizumab) Drug Revenue and Market Share by Countries (2013-2018)
5.2 United States Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
5.3 Canada Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
5.4 Mexico Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
6 Europe Entyvio (vedolizumab) Drug by Countries
6.1 Europe Entyvio (vedolizumab) Drug Sales, Revenue and Market Share by Countries
6.1.1 Europe Entyvio (vedolizumab) Drug Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Entyvio (vedolizumab) Drug Revenue and Market Share by Countries (2013-2018)
6.2 Germany Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
6.3 UK Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
6.4 France Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
6.5 Russia Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
6.6 Italy Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
7 Asia-Pacific Entyvio (vedolizumab) Drug by Countries
7.1 Asia-Pacific Entyvio (vedolizumab) Drug Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Entyvio (vedolizumab) Drug Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Entyvio (vedolizumab) Drug Revenue and Market Share by Countries (2013-2018)
7.2 China Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
7.3 Japan Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
7.4 Korea Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
7.5 India Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
8 South America Entyvio (vedolizumab) Drug by Countries
8.1 South America Entyvio (vedolizumab) Drug Sales, Revenue and Market Share by Countries
8.1.1 South America Entyvio (vedolizumab) Drug Sales and Market Share by Countries (2013-2018)
8.1.2 South America Entyvio (vedolizumab) Drug Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
8.3 Argentina Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
8.4 Colombia Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
9 Middle East and Africa Entyvio (vedolizumab) Drug by Countries
9.1 Middle East and Africa Entyvio (vedolizumab) Drug Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Entyvio (vedolizumab) Drug Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Entyvio (vedolizumab) Drug Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
9.3 UAE Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
9.4 Egypt Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
9.5 Nigeria Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
9.6 South Africa Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
10 Global Entyvio (vedolizumab) Drug Market Segment by Type
10.1 Global Entyvio (vedolizumab) Drug Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Entyvio (vedolizumab) Drug Sales and Market Share by Type (2013-2018)
10.1.2 Global Entyvio (vedolizumab) Drug Revenue and Market Share by Type (2013-2018)
10.2 Type 1 Sales Growth and Price
10.2.1 Global Type 1 Sales Growth (2013-2018)
10.2.2 Global Type 1 Price (2013-2018)
10.3 Type 2 Sales Growth and Price
10.3.1 Global Type 2 Sales Growth (2013-2018)
10.3.2 Global Type 2 Price (2013-2018)
11 Global Entyvio (vedolizumab) Drug Market Segment by Application
11.1 Global Entyvio (vedolizumab) Drug Sales Market Share by Application (2013-2018)
11.2 Ulcerative Colitis Sales Growth (2013-2018)
11.3 Crohn's Disease Sales Growth (2013-2018)
12 Entyvio (vedolizumab) Drug Market Forecast (2018-2023)
12.1 Global Entyvio (vedolizumab) Drug Sales, Revenue and Growth Rate (2018-2023)
12.2 Entyvio (vedolizumab) Drug Market Forecast by Regions (2018-2023)
12.2.1 North America Entyvio (vedolizumab) Drug Market Forecast (2018-2023)
12.2.2 Europe Entyvio (vedolizumab) Drug Market Forecast (2018-2023)
12.2.3 Asia-Pacific Entyvio (vedolizumab) Drug Market Forecast (2018-2023)
12.2.4 South America Entyvio (vedolizumab) Drug Market Forecast (2018-2023)
12.2.5 Middle East and Africa Entyvio (vedolizumab) Drug Market Forecast (2018-2023)
12.3 Entyvio (vedolizumab) Drug Market Forecast by Type (2018-2023)
12.3.1 Global Entyvio (vedolizumab) Drug Sales Forecast by Type (2018-2023)
12.3.2 Global Entyvio (vedolizumab) Drug Market Share Forecast by Type (2018-2023)
12.4 Entyvio (vedolizumab) Drug Market Forecast by Application (2018-2023)
12.4.1 Global Entyvio (vedolizumab) Drug Sales Forecast by Application (2018-2023)
12.4.2 Global Entyvio (vedolizumab) Drug Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Entyvio (vedolizumab) Drug Picture
Table Product Specifications of Entyvio (vedolizumab) Drug
Figure Global Sales Market Share of Entyvio (vedolizumab) Drug by Types in 2017
Table Entyvio (vedolizumab) Drug Types for Major Manufacturers
Figure Type 1 Picture
Figure Type 2 Picture
Figure Entyvio (vedolizumab) Drug Sales Market Share by Applications in 2017
Figure Ulcerative Colitis Picture
Figure Crohn's Disease Picture
Figure United States Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure France Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure UK Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure China Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure India Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)
Table Takeda Basic Information, Manufacturing Base and Competitors
Table Takeda Entyvio (vedolizumab) Drug Type and Applications
Table Takeda Entyvio (vedolizumab) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Entyvio (vedolizumab) Drug Sales by Manufacturer (2016-2017)
Figure Global Entyvio (vedolizumab) Drug Sales Market Share by Manufacturer in 2016
Figure Global Entyvio (vedolizumab) Drug Sales Market Share by Manufacturer in 2017
Table Global Entyvio (vedolizumab) Drug Revenue by Manufacturer (2016-2017)
Figure Global Entyvio (vedolizumab) Drug Revenue Market Share by Manufacturer in 2016
Figure Global Entyvio (vedolizumab) Drug Revenue Market Share by Manufacturer in 2017
Figure Top 3 Entyvio (vedolizumab) Drug Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Entyvio (vedolizumab) Drug Manufacturer (Revenue) Market Share in 2017
Figure Global Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
Figure Global Entyvio (vedolizumab) Drug Revenue and Growth Rate (2013-2018)
Table Global Entyvio (vedolizumab) Drug Sales by Regions (2013-2018)
Table Global Entyvio (vedolizumab) Drug Sales Market Share by Regions (2013-2018)
Table Global Entyvio (vedolizumab) Drug Revenue by Regions (2013-2018)
Figure Global Entyvio (vedolizumab) Drug Revenue Market Share by Regions in 2013
Figure Global Entyvio (vedolizumab) Drug Revenue Market Share by Regions in 2017
Figure North America Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
Figure Europe Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
Figure South America Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
Figure North America Entyvio (vedolizumab) Drug Revenue and Growth Rate (2013-2018)
Table North America Entyvio (vedolizumab) Drug Sales by Countries (2013-2018)
Table North America Entyvio (vedolizumab) Drug Sales Market Share by Countries (2013-2018)
Figure North America Entyvio (vedolizumab) Drug Sales Market Share by Countries in 2013
Figure North America Entyvio (vedolizumab) Drug Sales Market Share by Countries in 2017
Table North America Entyvio (vedolizumab) Drug Revenue by Countries (2013-2018)
Table North America Entyvio (vedolizumab) Drug Revenue Market Share by Countries (2013-2018)
Figure North America Entyvio (vedolizumab) Drug Revenue Market Share by Countries in 2013
Figure North America Entyvio (vedolizumab) Drug Revenue Market Share by Countries in 2017
Figure United States Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
Figure Canada Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
Figure Mexico Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
Figure Europe Entyvio (vedolizumab) Drug Revenue and Growth Rate (2013-2018)
Table Europe Entyvio (vedolizumab) Drug Sales by Countries (2013-2018)
Table Europe Entyvio (vedolizumab) Drug Sales Market Share by Countries (2013-2018)
Table Europe Entyvio (vedolizumab) Drug Revenue by Countries (2013-2018)
Figure Europe Entyvio (vedolizumab) Drug Revenue Market Share by Countries in 2016
Figure Europe Entyvio (vedolizumab) Drug Revenue Market Share by Countries in 2017
Figure Germany Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
Figure UK Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
Figure France Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
Figure Russia Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
Figure Italy Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Entyvio (vedolizumab) Drug Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Entyvio (vedolizumab) Drug Sales by Countries (2013-2018)
Table Asia-Pacific Entyvio (vedolizumab) Drug Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Entyvio (vedolizumab) Drug Sales Market Share by Countries 2017
Table Asia-Pacific Entyvio (vedolizumab) Drug Revenue by Countries (2013-2018)
Figure Asia-Pacific Entyvio (vedolizumab) Drug Revenue Market Share by Countries 2017
Figure China Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
Figure Japan Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
Figure Korea Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
Figure India Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
Figure Southeast Asia Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
Figure South America Entyvio (vedolizumab) Drug Revenue and Growth Rate (2013-2018)
Table South America Entyvio (vedolizumab) Drug Sales by Countries (2013-2018)
Table South America Entyvio (vedolizumab) Drug Sales Market Share by Countries (2013-2018)
Figure South America Entyvio (vedolizumab) Drug Sales Market Share by Countries in 2017
Table South America Entyvio (vedolizumab) Drug Revenue by Countries (2013-2018)
Table South America Entyvio (vedolizumab) Drug Revenue Market Share by Countries (2013-2018)
Figure South America Entyvio (vedolizumab) Drug Revenue Market Share by Countries in 2017
Figure Brazil Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
Figure Argentina Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
Figure Colombia Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Entyvio (vedolizumab) Drug Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Entyvio (vedolizumab) Drug Sales by Countries (2013-2018)
Table Middle East and Africa Entyvio (vedolizumab) Drug Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Entyvio (vedolizumab) Drug Sales Market Share by Countries in 2017
Table Middle East and Africa Entyvio (vedolizumab) Drug Revenue by Countries (2013-2018)
Table Middle East and Africa Entyvio (vedolizumab) Drug Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Entyvio (vedolizumab) Drug Revenue Market Share by Countries in 2013
Figure Middle East and Africa Entyvio (vedolizumab) Drug Revenue Market Share by Countries in 2017
Figure Saudi Arabia Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
Figure UAE Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
Figure Egypt Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
Figure Nigeria Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
Figure South Africa Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
Table Global Entyvio (vedolizumab) Drug Sales by Type (2013-2018)
Table Global Entyvio (vedolizumab) Drug Sales Share by Type (2013-2018)
Table Global Entyvio (vedolizumab) Drug Revenue by Type (2013-2018)
Table Global Entyvio (vedolizumab) Drug Revenue Share by Type (2013-2018)
Figure Global Type 1 Sales Growth (2013-2018)
Figure Global Type 1 Price (2013-2018)
Figure Global Type 2 Sales Growth (2013-2018)
Figure Global Type 2 Price (2013-2018)
Table Global Entyvio (vedolizumab) Drug Sales by Application (2013-2018)
Table Global Entyvio (vedolizumab) Drug Sales Share by Application (2013-2018)
Figure Global Crohn's Disease Sales Growth (2013-2018)
Figure Global Entyvio (vedolizumab) Drug Sales, Revenue and Growth Rate (2018-2023)
Table Global Entyvio (vedolizumab) Drug Sales Forecast by Regions (2018-2023)
Table Global Entyvio (vedolizumab) Drug Market Share Forecast by Regions (2018-2023)
Figure North America Sales Entyvio (vedolizumab) Drug Market Forecast (2018-2023)
Figure Europe Sales Entyvio (vedolizumab) Drug Market Forecast (2018-2023)
Figure Asia-Pacific Sales Entyvio (vedolizumab) Drug Market Forecast (2018-2023)
Figure South America Sales Entyvio (vedolizumab) Drug Market Forecast (2018-2023)
Figure Middle East and Africa Sales Entyvio (vedolizumab) Drug Market Forecast (2018-2023)
Table Global Entyvio (vedolizumab) Drug Sales Forecast by Type (2018-2023)
Table Global Entyvio (vedolizumab) Drug Market Share Forecast by Type (2018-2023)
Table Global Entyvio (vedolizumab) Drug Sales Forecast by Application (2018-2023)
Table Global Entyvio (vedolizumab) Drug Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List
  • NPWT Devices Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 19-Feb-2019        Price: US 3000 Onwards        Pages: 144
    NPWT Devices Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global NPWT Devices industry with a focus on the Chinese market. The report provides key statistics on the market status of the NPWT Devices manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provides an in-depth insight of 2014-2024 global and Chinese NPWT Devices market coverin......
  • Newborn Screening Instruments Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 19-Feb-2019        Price: US 3000 Onwards        Pages: 144
    Newborn Screening Instruments Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Newborn Screening Instruments industry with a focus on the Chinese market. The report provides key statistics on the market status of the Newborn Screening Instruments manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provides an in-depth insight of 2014-......
  • New Baby Monitoring System Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 19-Feb-2019        Price: US 3000 Onwards        Pages: 148
    New Baby Monitoring System Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global New Baby Monitoring System industry with a focus on the Chinese market. The report provides key statistics on the market status of the New Baby Monitoring System manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provides an in-depth insight of 2014-2024 glob......
  • Global Pit & Fissure Sealants Market Research Report 2019
    Published: 19-Feb-2019        Price: US 2900 Onwards        Pages: 109
    Pit & Fissure Sealant is a fluoride releasing light curing sealant for primary or permanent teeth. It is used in preventive dentistry where it has been clinically proven that sealants are effective in the prevention of caries. The fluoride that is released offers an additional protection against caries and its ideal viscosity allows it to penetrate into the deepest pits and fissures to ensure total sealing. The global Pit & Fissure Sealants market is valued at xx million US$ in 20......
  • Global Core Biopsy Needles Market Research Report 2019
    Published: 19-Feb-2019        Price: US 2900 Onwards        Pages: 96
    A core needle biopsy is a medical test to remove a piece of tissue from a lesion or mass. Core Biopsy Needle is the needles used for core needle biopsy. The global Core Biopsy Needles market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This report focuses on Core Biopsy Needles volume and value at global level, regional level and company level. From a global perspective, this report re......
  • Global Retractable Safety Syringes Market Research Report 2019
    Published: 19-Feb-2019        Price: US 2900 Onwards        Pages: 105
    Safety syringes are syringes developed with a safety mechanism to prevent needle stick and other injuries. The needle on a safety syringe can be detachable or permanently attached. The emphasis on preventing the re-use of syringes by safety bodies and governments has raised the demand for safety syringes. Syringes with retractable needles and syringes with protective shields are safety syringes widely used in hospitals. Retractable needle - the needle (usually fused to the syringe) is spring-loa......
  • Global Spine Surgical Devices Market Research Report 2019
    Published: 19-Feb-2019        Price: US 2900 Onwards        Pages: 104
    Spinal fusion products are used in spinal fusion surgery. The products are involved in removing the damaged disc and replacing it with any fusion products. Non-fusion products are used during spine surgery, which are implanted to treat spine conditions. This also allows the patient to retain its movement and flexibility. The non-fusion products are becoming the treatment of choice, especially for the younger, more active patient. Increase in number of spine surgeries, rise in use of bone grafts ......
  • Global Superabsorbent Dressings Market Research Report 2019
    Published: 19-Feb-2019        Price: US 2900 Onwards        Pages: 101
    Superabsorbent Dressings are multilayer wound protections, comprised of a semi or non-adhesive layers and extreme adsorptive layers of fibers. They are used as in management of severe exudating wounds such as ulcerating cancer wounds, dehiscence wounds, and exuding ulcers. The global Superabsorbent Dressings market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This report focuses on Sup......
  • Global Therapeutic Stents Market Research Report 2019
    Published: 19-Feb-2019        Price: US 2900 Onwards        Pages: 106
    Therapeutic stent is a metallic or a polymer tube implanted into the lumen of blood vessels or ducts to keep the passage open. A stent implant is commonly used for the treatment of cardiac abnormalities such as blocked blood vessels. In addition, stents are implanted in the esophagus to facilitate the passage of food & beverages in patients suffering from esophageal cancer. The global Therapeutic Stents market is valued at xx million US$ in 2018 is expected to reach xx million US$......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs